Market Research Life Sciences Market Research Medical Devices Market Research Cardiac Rhythm Management Market Research

Arrhythmia Market by Site Of Origin Atrial (Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia), Test Equipment (Electrocardiogram, Holter Monitor) - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 188 Pages 360iResearch January, 2024 IRE18418510
Best Price Guarantee
Price from $4,749
Length 188 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18418510

Arrhythmia Market by Site Of Origin Atrial (Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia), Test Equipment (Electrocardiogram, Holter Monitor) - Global Forecast 2024-2030


The Arrhythmia Market size was estimated at USD 6.01 billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 7.97% to reach USD 10.29 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Arrhythmia Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Arrhythmia Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Arrhythmia Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, AliveCor, Inc., AtriCure Inc., Biotricity, BIOTRONIK, Inc., Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd., Fukuda Denshi, GE Healthcare, GlaxoSmithKline PLC, Hill-Rom Holdings, Inc, iRhythm Technologies Inc., Koninklijke Philips NV, Medi-Lynx Cardiac Monitoring, LLC, Medtronic PLC, MicroPort Scientific Corporation, Nihon Kohden Corporation, Novartis AG, OSI Systems, Inc., Sanofi S.A., SCHILLER, Siemens Healthcare GmbH, and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Arrhythmia Market to forecast the revenues and analyze trends in each of the following sub-markets:

Site Of Origin Atrial

Atrial Tachycardia
  • Premature Atrial Contractions
  • Sinus Bradycardia
  • Wandering Atrial Pacemaker
  • Test Equipment

    Electrocardiogram
  • Holter Monitor
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Arrhythmia Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Arrhythmia Market?
    3. What are the technology trends and regulatory frameworks in the Arrhythmia Market?
    4. What is the market share of the leading vendors in the Arrhythmia Market?
    5. Which modes and strategic moves are suitable for entering the Arrhythmia Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Arrhythmia Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
    5.1.1.2. Trend of irrigated radiofrequency (RF) ablation catheter devices
    5.1.1.3. Rising awareness campaigns for arrhythmia
    5.1.2. Restraints
    5.1.2.1. High-cost associated with arrhythmia treatment and devices
    5.1.3. Opportunities
    5.1.3.1. Technological advancements in arrhythmia devices
    5.1.3.2. Robust research activities to develop new arrhythmia treatments
    5.1.4. Challenges
    5.1.4.1. Limitation of holter recordings for arrhythmia monitoring
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Arrhythmia Market, by Site Of Origin Atrial
    6.1. Introduction
    6.2. Atrial Tachycardia
    6.3. Premature Atrial Contractions
    6.4. Sinus Bradycardia
    6.5. Wandering Atrial Pacemaker
    7. Arrhythmia Market, by Test Equipment
    7.1. Introduction
    7.2. Electrocardiogram
    7.3. Holter Monitor
    8. Americas Arrhythmia Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Arrhythmia Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Arrhythmia Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. Abbott Laboratories
    12.1.2. ACS Diagnostics
    12.1.3. AliveCor, Inc.
    12.1.4. AtriCure Inc.
    12.1.5. Biotricity
    12.1.6. BIOTRONIK, Inc.
    12.1.7. Boston Scientific Corporation
    12.1.8. CardioFocus, Inc.
    12.1.9. CathRx Ltd.
    12.1.10. Fukuda Denshi
    12.1.11. GE Healthcare
    12.1.12. GlaxoSmithKline PLC
    12.1.13. Hill-Rom Holdings, Inc
    12.1.14. iRhythm Technologies Inc.
    12.1.15. Koninklijke Philips NV
    12.1.16. Medi-Lynx Cardiac Monitoring, LLC
    12.1.17. Medtronic PLC
    12.1.18. MicroPort Scientific Corporation
    12.1.19. Nihon Kohden Corporation
    12.1.20. Novartis AG
    12.1.21. OSI Systems, Inc.
    12.1.22. Sanofi S.A.
    12.1.23. SCHILLER
    12.1.24. Siemens Healthcare GmbH
    12.1.25. St. Jude Medical, Inc.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ARRHYTHMIA MARKET RESEARCH PROCESS
    FIGURE 2. ARRHYTHMIA MARKET SIZE, 2023 VS 2030
    FIGURE 3. ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ARRHYTHMIA MARKET DYNAMICS
    FIGURE 7. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2030 (%)
    FIGURE 8. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2030 (%)
    FIGURE 10. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings